Cargando…
Prevention of Obesity and Insulin Resistance by Estrogens Requires ERα Activation Function-2 (ERαAF-2), Whereas ERαAF-1 Is Dispensable
The beneficial metabolic actions of estrogen-based therapies are mainly mediated by estrogen receptor α (ERα), a nuclear receptor that regulates gene transcription through two activation functions (AFs): AF-1 and AF-2. Using mouse models deleted electively for ERαAF-1 (ERαAF-1°) or ERαAF-2 (ERαAF-2°...
Autores principales: | Handgraaf, Sandra, Riant, Elodie, Fabre, Aurélie, Waget, Aurélie, Burcelin, Rémy, Lière, Philippe, Krust, Andrée, Chambon, Pierre, Arnal, Jean-François, Gourdy, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837069/ https://www.ncbi.nlm.nih.gov/pubmed/23903353 http://dx.doi.org/10.2337/db13-0282 |
Ejemplares similares
-
SERMs have substance-specific effects on bone, and these effects are mediated via ERαAF-1 in female mice
por: Börjesson, Anna E., et al.
Publicado: (2016) -
Bisphenol AF Is a Full Agonist for the Estrogen Receptor ERα but a Highly Specific Antagonist for ERβ
por: Matsushima, Ayami, et al.
Publicado: (2010) -
The AF-1-deficient estrogen receptor ERα46 isoform is frequently expressed in human breast tumors
por: Chantalat, Elodie, et al.
Publicado: (2016) -
Membrane estrogen receptor-α contributes to female protection against high-fat diet-induced metabolic disorders
por: Fabre, Aurélie, et al.
Publicado: (2023) -
Extra-nuclear effects of estrogen on cortical bone in males require ERαAF-1
por: Farman, H H, et al.
Publicado: (2017)